|Videos|August 3, 2016

HAI Diagnostic Testing Strategies in Pediatric Healthcare

Thomas Sandora, MD, MPH, hospital epidemiologist at Boston Children’s Hospital, discusses some up and coming pediatric healthcare associated infection prevention strategies.

Thomas Sandora, MD, MPH, hospital epidemiologist at Boston Children’s Hospital, discusses some up and coming pediatric healthcare associated infection prevention strategies.

Interview Transcript (slightly modified for readability).

“[There are some prevention strategies] on the horizon that are really exciting.

One relates to diagnostic testing, so a good example is [Clostridium] difficile infection, which is a bacterial infection in the intestine that you can get after you’ve been exposed to antibiotics and can cause diarrhea. It’s difficult to test children for C. diff because they carry this [bacterium] in their intestines when they’re very young, even if it’s not causing any symptoms. So, using the current tests we have, it’s hard to tell who’s just carrying it and who actually has it as a cause of diarrhea.

There’s a new ultrasensitive test that’s being developed that tells you the amount of toxins that [are] present and we’re currently doing some research to try to determine if we can use those toxin levels to distinguish children who are just carrying the bacteria versus those who actually have diarrhea related to it. Some of these new diagnostic tests that are especially important for young children I think are going to help us in targeting treatment of disease appropriately.

Another area is something we call antimicrobial stewardship, which is overseeing the use of antibiotics and making sure that antibiotics are used appropriately [as well as] not using them when you don’t need them. This is a really important area for pediatrics because especially in outpatient clinics. At your general pediatrician’s office, there are so many visits for fever and for diseases that might be infections and kids get antibiotics a lot of times for viruses and for other scenarios where antibiotics don’t help. So, there’s a big emphasis on antibiotic stewardship and teaching outpatient providers about how to appropriately target when antibiotics are needed and when they won’t be helpful. I think that that’s going to make a big difference [in reducing] antibiotic resistant bacteria, which are becoming more and more of a problem.”


Related to this article

This Week's Top 5 Infectious Disease News Stories: September 12-September 18, 2026
In this week's top infectious disease stories, a Pennsylvania teen became the state's fourth measles death in weeks, the CDC reported a 17% summer surge in rabies exposure calls, new research revisited whether cefepime raises mortality risk, a multihospital review examined ceftriaxone's safety after state alerts, and examining Legionella pneumonia diagnostics.
Ceftriaxone Safety: Separating Signal From Risk
A retrospective multihospital study found that severe adverse events occurred at similarly low rates with ceftriaxone and other IV cephalosporins suggesting there is no evidence to support avoiding ceftriaxone despite recent health department safety alerts.
Treatment of Latent Tuberculosis in a Trice
A retrospective study of 225 patients across Cook County Department of Health clinics found that the novel 1-month 1HP regimen (isoniazid plus rifapentine) for latent TB infection had a completion rate comparable to standard longer regimens and was well tolerated, suggesting it may be a viable shorter alternative.
Peggy Lillis Foundation Will Honor C diff Advocates at Annual Gala
The Peggy Lillis Foundation will host its 17th Annual Changing the Odds Gala this month in New York City, and it will include a casino, fellowship amongst the C diff community, and an award ceremony honoring a physician-scientist, philanthropist, a researcher, and a patient advocate for their contributions to C difficile awareness, treatment, and prevention.